Author

M. Macoritto

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:human· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

H. Guay· 1 shared J. W. Davis· 1 shared J. Wang· 1 shared M. C. Levesque· 1 shared X. Cao· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

H. Guay

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The Clinical Response of Upadacitinib and Risankizumab is Associated with Reduced Inflammatory Bowel Disease Anti-TNFα Inadequate Response Mechanisms

J. Wang, M. Macoritto, H. Guay, J. W. Davis, M. C. Levesque, X. Cao

This study identifies TNF-IR up-regulated and down-regulated modules in IBD patients and shows that upadacitinib and risankizumab reduce TNF-IR up-regulated mechanisms in JAK1 responders.

bioRxiv · May 16, 2022 · PreprintImmunology